Introduction And Objectives: Changing unhealthy behaviors: Diet and physical activity are key to treating obesity. The objective of this study is to determine whether an intervention group motivational intervention group by nurses trained by expert psychologist, complementary to the usual intervention is more effective than the latter in the treatment of overweight and obesity in relation to weight reduction percentage and the persistence over time of the reduction achieved.
Methods: A multicenter randomized clinical trial of intervention in overweight and obese patients. Randomization of the intervention by health areas (ZBS). Two groups located in different centers separated, one of which will receive motivational intervention group (study group) and the other routine monitoring (control group) were established.
Variables: Sociodemographic, results: percentage of patients reduced by 5% of its weight and maintenance over time, anthropometric assessment, assessment of cardiovascular risk factors and laboratory data.
Results: 696 patients were studied; 377 control and 319 study group. In both groups the weight down in each of the visits. The mean percentage weight reduction stood at 1% for the control group and 2.5% in the intervention group (p -value = 0.009). 55.8% of patients reduced the weight in the control group and 65.5% of the study group (p -value = 0.0391). 18.1% of the control patient lost more than 5% by weight, in the intervention group, this percentage increased to 26.9%; statistically significant ( p -value = 0.0304). For the 10% target no significant differences at 2 years were detected (5% vs. 8%). It was found that after two years the BMI in the control group an average 0.9 kg/m2 and 2.4 kg/m2 was reduced in the study group ( p -value = 0.0237).
Conclusion: based motivational group intervention program can improve anthropometric and lifestyle parameters in obese patients treated in a primary care center.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3305/nh.2014.30.4.7704 | DOI Listing |
Hepatol Int
January 2025
Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Background/purpose: Although metabolic dysfunction-associated steatotic liver disease (MASLD) has been proposed to replace the diagnosis of non-alcoholic fatty liver disease (NAFLD) with new diagnostic criteria since 2023, the genetic predisposition of MASLD remains to be explored.
Methods: Participants with data of genome-wide association studies (GWAS) in the Taiwan Biobank database were collected. Patients with missing data, positive for HBsAg, anti-HCV, and alcohol drinking history were excluded.
J Robot Surg
January 2025
The Third Ward of Orthopaedic Department, General Hospital of Ningxia Medical University, 804 Shengli South Street, Hui Autonomous Region, Yinchuan, Ningxia, 750004, People's Republic of China.
The purpose of this study is to assess the safety and effectiveness of TiRobot-assisted treatment for femoral neck fractures, in comparison to traditional freehand treatment methods. Throughout the research process, we conducted an extensive literature search across numerous databases, including PubMed, EMBASE, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), CQVIP, and Wanfang. Based on the literature screening criteria, we selected six studies, encompassing 358 cases of femoral neck fracture patients, for this meta-analysis.
View Article and Find Full Text PDFClin Exp Med
January 2025
Universitat Autònoma de Barcelona, Bellaterra, Spain.
Alcohol-related cirrhosis (AC) is a condition that impacts in immunity. We analyzed changes over time in CD4subsets in AC-patients. We included patients with alcohol use disorder admitted at least twice for treatment.
View Article and Find Full Text PDFBreast Cancer Res Treat
January 2025
Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian , China.
Purpose: Age stratification influences the clinicopathological features and survival outcomes of breast cancer. We aimed to understand the effect of age on gene variants in young Chinese women with breast cancer compared with those from The Cancer Genome Atlas (TCGA).
Methods: Enrolled patients ≤ 40 years old (N = 370) underwent germline or somatic genetic testing using a 32-gene hereditary cancer panel at Fujian Union Hospital.
Breast Cancer Res Treat
January 2025
Division of Medical Oncology, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, 8700 Beverly Blvd., Los Angeles, CA, 90048, USA.
Purpose: There is an increasing incidence of young breast cancer (YBC) patients with uncertainty surrounding the factors and patterns that are contributing.
Methods: We obtained characteristics and survival data from 206,156 YBC patients (≤ 40 years of age) diagnosed between 2005 and 2019 from the National Cancer Database (NCDB). Patients were subdivided into two comparison groups based on year of diagnosis (2005-2009, Old vs.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!